.
Biotechnology
Canada Ahead of the Curve
Canada’s position as a biotechnology leader-one of the top five countries in the world-is a reflection of the country’s world-class credentials.
The biotech industry also benefits from powerful partnerships that strengthen government research dollars through collaboration with universities and industry, as well as progressive financing and venture capital programs for Canadian biotech enterprises.
Proven Research Strengths in:
- Genomics
- Proteomics
- Bio-informatics
- Immuno-therapies
- Protein engineering
- New drug delivery systems
- Vaccines
- Regenerative medicine (stem cells)
- Neuroscience
- Cardiovascular
Sexual disorders generally do not leave the man so easily or does not go away from the life of the man completely it can only be sold to an exporter who has this certificate. http://www.devensec.com/rules-regs/decregs1003.html order levitra online All medicines shall be discreetly shipped to your doorstep with any hassle. viagra cost india http://www.devensec.com/sustain/Transformations_Case_Study_FINAL_10-11-11.pdf online is a right place to search for an experienced doctor. levitra uk Purchase Generic Medicines Online from Online Generic Drug Store. It promotes to treat cialis generika http://www.devensec.com/rules-regs/decregs306.html kids with torticollis, spastic paralysis, spina bifida, and children with developmental problems.
Toronto has the largest faculty of medicine in North America and the output of peer-reviewed publications from this area is greater than any other medical centre in the world.
University of Toronto biomedical scientists have pioneered the genetic mechanisms for several diseases and discovered a way to increase the yield of stem calls from umbilical cord blood by removing unwanted cells that inhibit stem cell growth.
.
Life Sciences
From the identification of the muscular dystrophy gene, to discovering new ways of creating stem cells, Canada’s life sciences innovators are at the very forefront of discovery. Industry leaders are carving out global niches in biopharmaceuticals, medical devices and contract services-all thanks to Canada’s world-renowned research institutes and biotechnology clusters. Add on Canada’s 20-year patent protection, alongside its large pool of post-graduate and post-doctoral researchers, and the potential for innovation is limited only by our imagination.
With a significant and profitable healthcare market, Canada has become very attractive to life sciences companies. It is home to more than 390 pharmaceutical and 400 biotech companies that employed nearly 29,000 highly-skilled workers in 2007, making Canada the country with the third-largest number of biopharma firms in the world.
.
Biopharmaceuticals
Human health represents over half of all life science companies, 70 percent of all revenues and close to 90 percent of all R&D. Canada is globally recognized for: discovery and characterization of therapeutic molecules; genomics and proteomics platforms; vaccines and immunotherapeutics, regenerative medicine; and, stem cell research and drug formulation & delivery systems.
.
Contract Services
Canada is home to high-quality contract research and manufacturing services utilized by the world’s top pharmaceutical companies. As a result, we have become recognized for: advanced services in drug formulation and delivery systems; clinical trials; manufacturing and packaging; design and manufacture of high-value medical devices; and, analytical services.
.
Medical Devices
Some 1,000 small and medium-sized firms employ 26,000 people in this sector in Canada. In 2007, Canadian medical devices companies generated total revenues of $4 billion and exports of $2.4 billion. Canadian firms benefit from our strengths in related sectors such as advanced materials, microelectronics, and telecommunications, among others.
.
Pharmaceuticals
With an 9% annual growth rate, Canada is the third fastest growing market in the world for pharmaceuticals. The sector benefits from Canada’s thriving biotechnology industry, which also fuels pharmaceutical companies’ growth. Add to these advantages a well-educated workforce with highly-trained scientists and technicians, as well as business-friendly government policies, and it’s not surprising that nearly every major pharmaceutical company has manufacturing and/or R&D operations in Canada.
Why Canada provides a great business environment for all aspects of the pharmaceutical industry:
- Globally-recognized industry
- A vital, proactive approach to R&D
- Facilitated access to export markets
Companies in the Know Choose Canada
- Abbott Point of Care
- AstraZeneca
- Amgen
- Apotex
- Bristol-Myers Squibb
- GlaxoSmithKline
- Johnson & Johnson
- Merck Frosst
- Novartis
- Novopharm
- Pfizer
- Roche
- Sanofi-Aventis
- Schering-Plough
